Return On Equity of Voyager Therapeutics, Inc. from 30 Jun 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Voyager Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2016 to 30 Sep 2025.
  • Voyager Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -49%, a 688% decline year-over-year.
  • Voyager Therapeutics, Inc. annual Return On Equity for 2024 was -20%, a 131% decline from 2023.
  • Voyager Therapeutics, Inc. annual Return On Equity for 2023 was 64%.
  • Voyager Therapeutics, Inc. annual Return On Equity for 2022 was -68%, a 1.8% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Voyager Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -49% -57% -688% 01 Jul 2025 30 Sep 2025
Q2 2025 -38% -41% -1236% 01 Apr 2025 30 Jun 2025
Q1 2025 -27% -26% -2040% 01 Jan 2025 31 Mar 2025
Q4 2024 -20% -84% -131% 01 Oct 2024 31 Dec 2024
Q3 2024 8.3% -24% -74% 01 Jul 2024 30 Sep 2024
Q2 2024 3.3% -66% -95% 01 Apr 2024 30 Jun 2024
Q1 2024 -1.3% -96% -101% 01 Jan 2024 31 Mar 2024
Q4 2023 64% +131% 01 Oct 2023 31 Dec 2023
Q3 2023 32% +54% 01 Jul 2023 30 Sep 2023
Q2 2023 69% +144% 01 Apr 2023 30 Jun 2023
Q1 2023 95% +172% 01 Jan 2023 31 Mar 2023
Q4 2022 -68% -1.2% -1.8% 01 Oct 2022 31 Dec 2022
Q3 2022 -22% +54% +71% 01 Jul 2022 30 Sep 2022
Q2 2022 -75% -88% -695% 01 Apr 2022 30 Jun 2022
Q1 2022 -77% -106% -360% 01 Jan 2022 31 Mar 2022
Q4 2021 -66% -97% -315% 01 Oct 2021 31 Dec 2021
Q3 2021 -76% -114% -300% 01 Jul 2021 30 Sep 2021
Q2 2021 13% +79% 01 Apr 2021 30 Jun 2021
Q1 2021 30% +70% 01 Jan 2021 31 Mar 2021
Q4 2020 31% +72% 01 Oct 2020 31 Dec 2020
Q3 2020 38% +95% 01 Jul 2020 30 Sep 2020
Q2 2020 -66% +4.6% +6.5% 01 Apr 2020 30 Jun 2020
Q1 2020 -40% +90% +69% 01 Jan 2020 31 Mar 2020
Q4 2019 -41% +80% +66% 01 Oct 2019 31 Dec 2019
Q3 2019 -57% +24% +30% 01 Jul 2019 30 Sep 2019
Q2 2019 -71% +9.7% +12% 01 Apr 2019 30 Jun 2019
Q1 2019 -130% -60% -85% 01 Jan 2019 31 Mar 2019
Q4 2018 -121% -58% -91% 01 Oct 2018 31 Dec 2018
Q3 2018 -82% -16% -25% 01 Jul 2018 30 Sep 2018
Q2 2018 -81% -35% -75% 01 Apr 2018 30 Jun 2018
Q1 2018 -70% -35% -99% 01 Jan 2018 31 Mar 2018
Q4 2017 -63% -37% -138% 01 Oct 2017 31 Dec 2017
Q3 2017 -66% -45% -218% 01 Jul 2017 30 Sep 2017
Q2 2017 -46% -21% -84% 01 Apr 2017 30 Jun 2017
Q1 2017 -35% 01 Jan 2017 31 Mar 2017
Q4 2016 -27% 01 Oct 2016 31 Dec 2016
Q3 2016 -21% 01 Jul 2016 30 Sep 2016
Q2 2016 -25% 01 Apr 2016 30 Jun 2016

Voyager Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -20% -84% -131% 01 Jan 2024 31 Dec 2024
2023 64% +131% 01 Jan 2023 31 Dec 2023
2022 -68% -1.2% -1.8% 01 Jan 2022 31 Dec 2022
2021 -66% -97% -315% 01 Jan 2021 31 Dec 2021
2020 31% +72% 01 Jan 2020 31 Dec 2020
2019 -41% +80% +66% 01 Jan 2019 31 Dec 2019
2018 -121% -58% -91% 01 Jan 2018 31 Dec 2018
2017 -63% -37% -138% 01 Jan 2017 31 Dec 2017
2016 -27% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.